MedTrace Logo

Treatment Trial for Post-Thrombotic Syndrome

NCT00633971 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2020-09-17

No results posted yet for this study

Summary

The purpose of this study is to determine if complex lymphedema therapy is effective in decreasing disease severity and improving quality of life in patients with post thrombotic syndrome.

Conditions

  • Post Thrombotic Syndrome

Interventions

OTHER

complex lymphedema therapy

Patients with established post thrombotic syndrome will be randomized to either compression stocking use or complex lymphedema therapy.

Sponsors & Collaborators

  • University of Vermont

    lead OTHER

Principal Investigators

  • Chris E Holmes, MD, PhD · University of Vermont and Fletcher Allen Health Care

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-06-30
Completion
2011-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00633971 on ClinicalTrials.gov